David GeffnerDavid Lewis Geffner, M.D., F.A.C.P., F.A.C.E., Associate Physician Diplomat
Clinical Professor Department of Medicine
David Geffen School of Medicine at UCLA

Dr. Geffner is a practicing adult and pediatric endocrinologist who has worked for large medical groups across Southern California.

After obtaining his M.D. at Georgetown University School of Medicine he did his internship and subsequently his residency at the Cornell Cooperating Hospital House Staff Training Program in New York. He finished fellowships in endocrinology at the New York Hospital and UCLA-Wadsworth VA where he became Assistant Chief of Endocrinology before leaving for clinical practice. He continues to teach courses and was a member of the Committee on Scientific Integrity at UCLA where he is a full clinical professor. When his is not seeing patients he is teaching fellows, residents, and medical students at UCLA affiliated hospitals.

He is a member of several professional societies including the Endocrine Society, the American Association of Clinical Endocrinologists, and the American Thyroid Association. He has served on several national and local committees for several of these organizations. He is past President of the Los Angeles County Chapter of the American Diabetes Association and is an advisor to groups such as The American College of Medical Quality and the Rand Corp. He presently consults for the Medical Board of California of which he was a member, for Medicare, and for the Center for Health Dispute Resolution. He was a JACO surveyor for the California Department of Health Services and Institute for Medical Quality.

He is an invited speaker at national, professional, and community meetings and has served on the editorial advisory boards and review panels for several journals as well as publishing original articles in the fields of thyroid, diabetes, calcium, adrenal, sexual function, delivery of health care, and disease state management.

He is the co-chair of the Thyroid Disorders Educational Initiative and a speaker for the Diabetes Educational Initiative and several pharmaceutical companies.

 

Pubmed Link